Venous thromboembolism and transfusion outcomes following intravenous tranexamic acid in primary total hip arthroplasty: A prospective two-center cohort study

INTRODUCTION: Tranexamic acid (TXA) is widely used during total hip arthroplasty (THA) to reduce perioperative blood loss and transfusion requirements. Although extensive evidence supports its use, prospective real-world data from Latin America are limited. This study aimed to describe the incidence of symptomatic venous thromboembolism (VTE) and blood transfusion among patients receiving intravenous TXA during primary total hip arthroplasty (THA) at two institutions in Bogotá, Colombia. METHODS: This prospective, observational, descriptive, two-center cohort study included consecutive adults who underwent elective primary THA. Patients received intravenous TXA according to institutional protocols. The primary outcome was the occurrence of symptomatic VTE, including deep vein thrombosis (DVT), pulmonary embolism, ischemic stroke, and myocardial infarction during a 10-week follow-up period. The secondary outcomes included blood transfusion requirements, postoperative hemoglobin levels, and emergency department visits. RESULTS: A total of 151 primary THAs were performed in 133 patients. One case of symptomatic DVT was diagnosed, corresponding to a VTE incidence of 0.75%. Five patients (3.8%) required postoperative blood transfusions, including two complex reconstructive procedures. The mean postoperative hemoglobin level was 11.8 ± 1.9 g/dL. No pulmonary embolism, ischemic stroke, or myocardial infarction was observed during the follow-up period. CONCLUSIONS: In this prospective two-center cohort of patients receiving intravenous TXA during primary THA, including both conventional and complex cases, a low incidence of symptomatic VTE and transfusion was observed. These results provide prospective real-world evidence from a Latin American population and contribute to the regional literature on perioperative blood conservation strategies for primary THA.

Authors

Institutions

Publication Details

Journal
SICOT-J
Published
2026-11-13
DOI
https://doi.org/10.1051/sicotj/2026068
Primary Topic
Blood transfusion and management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Venous thromboembolism and transfusion outcomes following intravenous tranexamic acid in primary total hip arthroplasty: A prospective two-center cohort study

Sofía Elizabeth Muñoz Medina, David A. Rincón‐Valenzuela, Jairo Alonso Rincón-Hoyos, Andrés Restrepo et al.
1 links
SICOT-J
Blood transfusion and management
article

Venous thromboembolism and transfusion outcomes following intravenous tranexamic acid in primary total hip arthroplasty: A prospective two-center cohort study

Sofía Elizabeth Muñoz Medina, David A. Rincón‐Valenzuela, Jairo Alonso Rincón-Hoyos, Andrés Restrepo, Jorge Casas, Alejandro Torres-Mayorga, Jorge Manrique
article en

Abstract

INTRODUCTION: Tranexamic acid (TXA) is widely used during total hip arthroplasty (THA) to reduce perioperative blood loss and transfusion requirements. Although extensive evidence supports its use, prospective real-world data from Latin America are limited. This study aimed to describe the incidence of symptomatic venous thromboembolism (VTE) and blood transfusion among patients receiving intravenous TXA during primary total hip arthroplasty (THA) at two institutions in Bogotá, Colombia. METHODS: This prospective, observational, descriptive, two-center cohort study included consecutive adults who underwent elective primary THA. Patients received intravenous TXA according to institutional protocols. The primary outcome was the occurrence of symptomatic VTE, including deep vein thrombosis (DVT), pulmonary embolism, ischemic stroke, and myocardial infarction during a 10-week follow-up period. The secondary outcomes included blood transfusion requirements, postoperative hemoglobin levels, and emergency department visits. RESULTS: A total of 151 primary THAs were performed in 133 patients. One case of symptomatic DVT was diagnosed, corresponding to a VTE incidence of 0.75%. Five patients (3.8%) required postoperative blood transfusions, including two complex reconstructive procedures. The mean postoperative hemoglobin level was 11.8 ± 1.9 g/dL. No pulmonary embolism, ischemic stroke, or myocardial infarction was observed during the follow-up period. CONCLUSIONS: In this prospective two-center cohort of patients receiving intravenous TXA during primary THA, including both conventional and complex cases, a low incidence of symptomatic VTE and transfusion was observed. These results provide prospective real-world evidence from a Latin American population and contribute to the regional literature on perioperative blood conservation strategies for primary THA.

SICOT-JVol. 12
Fundación Universitaria Sanitas (CO)
Good health and well-being
Blood transfusion and management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon